Compare RCMT & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCMT | KRMD |
|---|---|---|
| Founded | 1971 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.1M | 192.5M |
| IPO Year | 1997 | 2019 |
| Metric | RCMT | KRMD |
|---|---|---|
| Price | $34.70 | $3.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $36.00 | $6.50 |
| AVG Volume (30 Days) | 27.5K | ★ 229.6K |
| Earning Date | 04-03-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.38 | ★ 53.85 |
| EPS | ★ 1.20 | N/A |
| Revenue | ★ $186,737,000.00 | $41,127,366.00 |
| Revenue This Year | $11.89 | $20.32 |
| Revenue Next Year | $12.46 | $17.37 |
| P/E Ratio | $55.62 | ★ N/A |
| Revenue Growth | 5.83 | ★ 22.23 |
| 52 Week Low | $17.26 | $3.21 |
| 52 Week High | $32.50 | $6.61 |
| Indicator | RCMT | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 82.90 | 32.01 |
| Support Level | $27.02 | $3.21 |
| Resistance Level | N/A | $4.27 |
| Average True Range (ATR) | 1.03 | 0.22 |
| MACD | 0.37 | -0.07 |
| Stochastic Oscillator | 94.46 | 12.72 |
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions, including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, and Europe.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.